These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 372531)
1. Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis. Van Dijk WC; Verbrugh HA; Peters R; Van Der Tol ME; Peterson PK; Verhoef J J Med Microbiol; 1979 Feb; 12(1):123-30. PubMed ID: 372531 [TBL] [Abstract][Full Text] [Related]
2. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing. Allen PM; Fisher D; Saunders JR; Hart CA J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374 [TBL] [Abstract][Full Text] [Related]
3. Killing of Escherichia coli strains from clinical specimens in human serum and polymorphonuclear leucocytes. Kumar S; Rizvi M Indian J Pathol Microbiol; 2002 Apr; 45(2):173-5. PubMed ID: 12696734 [TBL] [Abstract][Full Text] [Related]
4. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Verhoef J Infect Immun; 1979 Aug; 25(2):603-9. PubMed ID: 385502 [TBL] [Abstract][Full Text] [Related]
5. K-1 antigen content and the presence of an additional sialic acid-containing antigen among bacteremic K-1 Escherichia coli: correlation with susceptibility to opsonophagocytosis. Stevens P; Chu CL; Young LS Infect Immun; 1980 Sep; 29(3):1055-61. PubMed ID: 7000702 [TBL] [Abstract][Full Text] [Related]
6. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli. Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498 [TBL] [Abstract][Full Text] [Related]
7. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization. Bortolussi R; Ferrieri P; Quie PG Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228 [TBL] [Abstract][Full Text] [Related]
8. Serum sensitivity of a diversity of Escherichia coli antigenic reference strains. Correlation with an LPS variation phenomenon. Stawski G; Nielsen L; Orskov F; Orskov I APMIS; 1990 Sep; 98(9):828-38. PubMed ID: 1699558 [TBL] [Abstract][Full Text] [Related]
9. K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model. Verweij-van Vught AM; van den Bosch JF; Namavar F; Sparrius M; MacLaren DM J Med Microbiol; 1983 May; 16(2):147-55. PubMed ID: 6341596 [TBL] [Abstract][Full Text] [Related]
10. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains. Veringa E; Box A; Rozenberg-Arska M; Verhoef J Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179 [TBL] [Abstract][Full Text] [Related]
11. Pre-opsonisation of Escherichia coli induces resistance to neutrophil killing in serum and urine: relationship to growth phase. Gargan RA; Brumfitt W; Hamilton-Miller JM J Med Microbiol; 1991 Jul; 35(1):12-7. PubMed ID: 1677047 [TBL] [Abstract][Full Text] [Related]
12. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1. Allen PM; Roberts I; Boulnois GJ; Saunders JR; Hart CA Infect Immun; 1987 Nov; 55(11):2662-8. PubMed ID: 3312006 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1. Franiczek R; Jankowski S Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615 [TBL] [Abstract][Full Text] [Related]
14. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953 [TBL] [Abstract][Full Text] [Related]
15. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. Horwitz MA; Silverstein SC J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617 [TBL] [Abstract][Full Text] [Related]
17. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli. Welch WD; Martin WJ; Stevens P; Young LS Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778 [TBL] [Abstract][Full Text] [Related]
18. Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes. Rozenberg-Arska M; Salters ME; van Strijp JA; Geuze JJ; Verhoef J Infect Immun; 1985 Dec; 50(3):852-9. PubMed ID: 3905616 [TBL] [Abstract][Full Text] [Related]
19. Correlation between phagocytic activity and metabolic response of polymorphonuclear leukocytes toward different strains of Escherichia coli. Rottini G; Dri P; Soranzo MR; Patriarca P Infect Immun; 1975 Mar; 11(3):417-23. PubMed ID: 1090529 [TBL] [Abstract][Full Text] [Related]
20. Response of Escherichia coli strains carrying plasmid(s) and their plasmidless derivatives to bactericidal activity of human serum and polymorphonuclear leukocytes. Siegfried L; Puzová H Acta Microbiol Hung; 1991; 38(2):107-15. PubMed ID: 1805497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]